

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.87401501 |
| 2 | NADH metabolic process (GO:0006734) | 5.81367043 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 5.63288566 |
| 4 | succinate metabolic process (GO:0006105) | 5.22839169 |
| 5 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.86165358 |
| 6 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.76066186 |
| 7 | oxaloacetate metabolic process (GO:0006107) | 4.68821034 |
| 8 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.64366712 |
| 9 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.58506459 |
| 10 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.46916964 |
| 11 | negative regulation of ligase activity (GO:0051352) | 4.46916964 |
| 12 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.36784000 |
| 13 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.34696323 |
| 14 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.34557995 |
| 15 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.27093110 |
| 16 | cullin deneddylation (GO:0010388) | 4.25828934 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 4.23208419 |
| 18 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.20079986 |
| 19 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.20079986 |
| 20 | regulation of coenzyme metabolic process (GO:0051196) | 4.16644628 |
| 21 | regulation of cofactor metabolic process (GO:0051193) | 4.16644628 |
| 22 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.16056697 |
| 23 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.16056697 |
| 24 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.16056697 |
| 25 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.15880818 |
| 26 | ribosome assembly (GO:0042255) | 4.13432259 |
| 27 | protein deneddylation (GO:0000338) | 4.11811232 |
| 28 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.04866118 |
| 29 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.04866118 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 4.02339941 |
| 31 | COPI coating of Golgi vesicle (GO:0048205) | 4.02339941 |
| 32 | glutamate secretion (GO:0014047) | 3.98223072 |
| 33 | positive regulation of ligase activity (GO:0051351) | 3.97992243 |
| 34 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.96882398 |
| 35 | neuronal action potential propagation (GO:0019227) | 3.96478540 |
| 36 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.76659700 |
| 37 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.75765387 |
| 38 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.75765387 |
| 39 | tRNA aminoacylation for protein translation (GO:0006418) | 3.75497909 |
| 40 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.67147969 |
| 41 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.66570882 |
| 42 | amino acid activation (GO:0043038) | 3.66069035 |
| 43 | tRNA aminoacylation (GO:0043039) | 3.66069035 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.63660821 |
| 45 | regulation of ligase activity (GO:0051340) | 3.63278816 |
| 46 | regulation of cellular amine metabolic process (GO:0033238) | 3.62972636 |
| 47 | neurotransmitter secretion (GO:0007269) | 3.61976971 |
| 48 | establishment of integrated proviral latency (GO:0075713) | 3.59285773 |
| 49 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.55838593 |
| 50 | lysine metabolic process (GO:0006553) | 3.51771899 |
| 51 | lysine catabolic process (GO:0006554) | 3.51771899 |
| 52 | aspartate family amino acid catabolic process (GO:0009068) | 3.50753451 |
| 53 | synaptic vesicle maturation (GO:0016188) | 3.49574584 |
| 54 | dicarboxylic acid catabolic process (GO:0043649) | 3.48272440 |
| 55 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.45908523 |
| 56 | vocalization behavior (GO:0071625) | 3.44699538 |
| 57 | protein maturation by protein folding (GO:0022417) | 3.41885907 |
| 58 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.39833666 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.39631120 |
| 60 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.38718907 |
| 61 | formation of translation preinitiation complex (GO:0001731) | 3.37963731 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.33331874 |
| 63 | regulation of synaptic vesicle transport (GO:1902803) | 3.31017234 |
| 64 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.30871138 |
| 65 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.28675281 |
| 66 | respiratory electron transport chain (GO:0022904) | 3.27018842 |
| 67 | transferrin transport (GO:0033572) | 3.24863989 |
| 68 | gamma-aminobutyric acid transport (GO:0015812) | 3.23688188 |
| 69 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.22712854 |
| 70 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.18163676 |
| 71 | electron transport chain (GO:0022900) | 3.17280535 |
| 72 | regulation of mitochondrial translation (GO:0070129) | 3.14742417 |
| 73 | positive regulation of cell cycle arrest (GO:0071158) | 3.14235674 |
| 74 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.13416568 |
| 75 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.13416568 |
| 76 | regulation of sulfur metabolic process (GO:0042762) | 3.11364580 |
| 77 | ferric iron transport (GO:0015682) | 3.11143479 |
| 78 | trivalent inorganic cation transport (GO:0072512) | 3.11143479 |
| 79 | 2-oxoglutarate metabolic process (GO:0006103) | 3.10337949 |
| 80 | protein targeting to mitochondrion (GO:0006626) | 3.10045219 |
| 81 | striatum development (GO:0021756) | 3.09774812 |
| 82 | gluconeogenesis (GO:0006094) | 3.09016698 |
| 83 | negative regulation of protein ubiquitination (GO:0031397) | 3.08555637 |
| 84 | chaperone-mediated protein transport (GO:0072321) | 3.06244061 |
| 85 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.01092500 |
| 86 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.00043936 |
| 87 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.99160269 |
| 88 | aerobic respiration (GO:0009060) | 2.98363729 |
| 89 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.98098418 |
| 90 | establishment of viral latency (GO:0019043) | 2.96715576 |
| 91 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.96083805 |
| 92 | neuromuscular process controlling posture (GO:0050884) | 2.95883309 |
| 93 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.94523409 |
| 94 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.94096913 |
| 95 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.92883130 |
| 96 | hexose biosynthetic process (GO:0019319) | 2.92310739 |
| 97 | activation of protein kinase A activity (GO:0034199) | 2.91771234 |
| 98 | locomotory exploration behavior (GO:0035641) | 2.91541446 |
| 99 | cellular potassium ion homeostasis (GO:0030007) | 2.91522223 |
| 100 | ATP synthesis coupled proton transport (GO:0015986) | 2.91408417 |
| 101 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.91408417 |
| 102 | neuron-neuron synaptic transmission (GO:0007270) | 2.91394938 |
| 103 | protein localization to mitochondrion (GO:0070585) | 2.90432277 |
| 104 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.90325322 |
| 105 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.90179104 |
| 106 | neurotransmitter transport (GO:0006836) | 2.89651695 |
| 107 | ribonucleoprotein complex disassembly (GO:0032988) | 2.89444969 |
| 108 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.89390194 |
| 109 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.89267015 |
| 110 | de novo protein folding (GO:0006458) | 2.86423856 |
| 111 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.86333539 |
| 112 | glutamate metabolic process (GO:0006536) | 2.82639711 |
| 113 | proline transport (GO:0015824) | 2.82596570 |
| 114 | regulation of cellular respiration (GO:0043457) | 2.81641248 |
| 115 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.81571336 |
| 116 | establishment of protein localization to mitochondrion (GO:0072655) | 2.81324792 |
| 117 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.80697478 |
| 118 | IMP biosynthetic process (GO:0006188) | 2.80635119 |
| 119 | cellular respiration (GO:0045333) | 2.80489926 |
| 120 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.79394558 |
| 121 | behavioral response to cocaine (GO:0048148) | 2.79360996 |
| 122 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.78920973 |
| 123 | de novo posttranslational protein folding (GO:0051084) | 2.77892749 |
| 124 | purine nucleobase biosynthetic process (GO:0009113) | 2.77241671 |
| 125 | L-methionine salvage (GO:0071267) | 2.76885244 |
| 126 | L-methionine biosynthetic process (GO:0071265) | 2.76885244 |
| 127 | amino acid salvage (GO:0043102) | 2.76885244 |
| 128 | regulation of neurotransmitter levels (GO:0001505) | 2.76785927 |
| 129 | cell cycle G1/S phase transition (GO:0044843) | 2.76670277 |
| 130 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.76670277 |
| 131 | cellular ketone body metabolic process (GO:0046950) | 2.75639250 |
| 132 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.74745414 |
| 133 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.74745414 |
| 134 | respiratory chain complex IV assembly (GO:0008535) | 2.72163620 |
| 135 | branched-chain amino acid catabolic process (GO:0009083) | 2.71612706 |
| 136 | oxidative phosphorylation (GO:0006119) | 2.71577681 |
| 137 | positive regulation of protein ubiquitination (GO:0031398) | 2.69924659 |
| 138 | glycolytic process (GO:0006096) | 2.69754602 |
| 139 | IMP metabolic process (GO:0046040) | 2.69646306 |
| 140 | inner mitochondrial membrane organization (GO:0007007) | 2.68409454 |
| 141 | regulation of synapse structural plasticity (GO:0051823) | 2.68254950 |
| 142 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.67854557 |
| 143 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.67854557 |
| 144 | monosaccharide biosynthetic process (GO:0046364) | 2.67668211 |
| 145 | NAD metabolic process (GO:0019674) | 2.67187676 |
| 146 | mitochondrial transport (GO:0006839) | 2.67183110 |
| 147 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.65908299 |
| 148 | signal transduction in response to DNA damage (GO:0042770) | 2.65406500 |
| 149 | organelle disassembly (GO:1903008) | 2.64743837 |
| 150 | tricarboxylic acid metabolic process (GO:0072350) | 2.62163721 |
| 151 | regulation of cell communication by electrical coupling (GO:0010649) | 2.58464424 |
| 152 | protein localization to synapse (GO:0035418) | 2.56084674 |
| 153 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.55935106 |
| 154 | long-term synaptic potentiation (GO:0060291) | 2.55280213 |
| 155 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.53459225 |
| 156 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.51590716 |
| 157 | acetyl-CoA metabolic process (GO:0006084) | 2.50166228 |
| 158 | female mating behavior (GO:0060180) | 2.49808150 |
| 159 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.49778067 |
| 160 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.48831342 |
| 161 | sodium ion export (GO:0071436) | 2.48120489 |
| 162 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.46967982 |
| 163 | synaptic transmission, glutamatergic (GO:0035249) | 2.46674009 |
| 164 | fatty acid beta-oxidation (GO:0006635) | 2.46034369 |
| 165 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.45403829 |
| 166 | regulation of female receptivity (GO:0045924) | 2.44949358 |
| 167 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.44294108 |
| 168 | branched-chain amino acid metabolic process (GO:0009081) | 2.43709344 |
| 169 | cell communication by electrical coupling (GO:0010644) | 2.43629617 |
| 170 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.43487961 |
| 171 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.40676922 |
| 172 | regulation of glutamate secretion (GO:0014048) | 2.40215029 |
| 173 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.40153542 |
| 174 | detection of calcium ion (GO:0005513) | 2.40070374 |
| 175 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.39988556 |
| 176 | thioester biosynthetic process (GO:0035384) | 2.39940960 |
| 177 | acyl-CoA biosynthetic process (GO:0071616) | 2.39940960 |
| 178 | neuron cell-cell adhesion (GO:0007158) | 2.37580053 |
| 179 | short-chain fatty acid metabolic process (GO:0046459) | 2.36122518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.31289298 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.16560739 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.09965978 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.85658044 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.83938844 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.81319599 |
| 7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.80014204 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.78765637 |
| 9 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.71694011 |
| 10 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.69496704 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.60521379 |
| 12 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.53756091 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.53610614 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.41154520 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.14457776 |
| 16 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.11450152 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.10742806 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.02491593 |
| 19 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.73533064 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.69114847 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.69000018 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.63926847 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.62976372 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.53692460 |
| 25 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.52254171 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.50975356 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.45187407 |
| 28 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.42122258 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.40399130 |
| 30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.40296627 |
| 31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.38546472 |
| 32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.35650312 |
| 33 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.34975025 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28887351 |
| 35 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.27400818 |
| 36 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25333919 |
| 37 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.23200688 |
| 38 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.16450378 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.16417048 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.15224006 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.11946241 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.04676588 |
| 43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.01836183 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01470534 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.99688271 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99323271 |
| 47 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.99094974 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98093720 |
| 49 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.97411380 |
| 50 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.95244638 |
| 51 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.94450762 |
| 52 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.90558157 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88082933 |
| 54 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.85958016 |
| 55 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.85958016 |
| 56 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85804775 |
| 57 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.84657120 |
| 58 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.83789724 |
| 59 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.80053959 |
| 60 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.78365279 |
| 61 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.77842919 |
| 62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.77730664 |
| 63 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76739342 |
| 64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73532640 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73489714 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73438983 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72761529 |
| 68 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.68402051 |
| 69 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67207361 |
| 70 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.65115320 |
| 71 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.62061594 |
| 72 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.58263072 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57697115 |
| 74 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55601560 |
| 75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.55248307 |
| 76 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.54358398 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54319637 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53318340 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52634691 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51235734 |
| 81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50776281 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.47683982 |
| 83 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46721291 |
| 84 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44778058 |
| 85 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.44507039 |
| 86 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.42370860 |
| 87 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41561025 |
| 88 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.41286562 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39914874 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.39500621 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.39305908 |
| 92 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38841590 |
| 93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.38468798 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38074177 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38074177 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35159781 |
| 97 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34168093 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33427382 |
| 99 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32029661 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31671020 |
| 101 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.29797568 |
| 102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29660699 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27308163 |
| 104 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26084992 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25991257 |
| 106 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.25802808 |
| 107 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25583549 |
| 108 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25434456 |
| 109 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.23885312 |
| 110 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.23669990 |
| 111 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23102656 |
| 112 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22934914 |
| 113 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21210029 |
| 114 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20838598 |
| 115 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20589498 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18057639 |
| 117 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17934546 |
| 118 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.17619640 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16429809 |
| 120 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16342219 |
| 121 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16004044 |
| 122 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15616980 |
| 123 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09224207 |
| 124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08988996 |
| 125 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08958209 |
| 126 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08958209 |
| 127 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.08176263 |
| 128 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08145278 |
| 129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07811227 |
| 130 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06098842 |
| 131 | JUN_21703547_ChIP-Seq_K562_Human | 1.05597910 |
| 132 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.04888227 |
| 133 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04522181 |
| 134 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.02841241 |
| 135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02390987 |
| 136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02364656 |
| 137 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01643587 |
| 138 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00868786 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00366119 |
| 140 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99894507 |
| 141 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99726048 |
| 142 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99295248 |
| 143 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.98781187 |
| 144 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98750520 |
| 145 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98589733 |
| 146 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98570795 |
| 147 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98501764 |
| 148 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98320807 |
| 149 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97962698 |
| 150 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.97149473 |
| 151 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96790693 |
| 152 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.96168744 |
| 153 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96105750 |
| 154 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.95120878 |
| 155 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94471346 |
| 156 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.94146261 |
| 157 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93132086 |
| 158 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92193219 |
| 159 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92193219 |
| 160 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92095813 |
| 161 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91407350 |
| 162 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90586038 |
| 163 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89723546 |
| 164 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89316499 |
| 165 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88886060 |
| 166 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88126613 |
| 167 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87922516 |
| 168 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.87302163 |
| 169 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.87127250 |
| 170 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.86438398 |
| 171 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85979003 |
| 172 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.85972730 |
| 173 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85939475 |
| 174 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.85580970 |
| 175 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.84885657 |
| 176 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84704189 |
| 177 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.84205093 |
| 178 | AR_19668381_ChIP-Seq_PC3_Human | 0.83324477 |
| 179 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82908871 |
| 180 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81981170 |
| 181 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.80694724 |
| 182 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80659549 |
| 183 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.80546108 |
| 184 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.79945478 |
| 185 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.79498705 |
| 186 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.76300350 |
| 187 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.74539243 |
| 188 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.74236410 |
| 189 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.72069193 |
| 190 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70859470 |
| 191 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.70241988 |
| 192 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.70053335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.04457259 |
| 2 | MP0003880_abnormal_central_pattern | 3.54056779 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.16469386 |
| 4 | MP0002822_catalepsy | 3.13378667 |
| 5 | MP0008058_abnormal_DNA_repair | 3.08182593 |
| 6 | MP0009046_muscle_twitch | 3.01692046 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 3.01683005 |
| 8 | MP0003186_abnormal_redox_activity | 2.93845932 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 2.88132286 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.87454322 |
| 11 | MP0003646_muscle_fatigue | 2.72732465 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.71570816 |
| 13 | MP0009745_abnormal_behavioral_response | 2.69978507 |
| 14 | MP0002064_seizures | 2.68395652 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.46776324 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.43203788 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.42416281 |
| 18 | MP0004270_analgesia | 2.41436451 |
| 19 | MP0003786_premature_aging | 2.27338218 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.26818253 |
| 21 | MP0002736_abnormal_nociception_after | 2.21974088 |
| 22 | MP0008007_abnormal_cellular_replicative | 2.20706050 |
| 23 | MP0002272_abnormal_nervous_system | 2.17498362 |
| 24 | MP0009697_abnormal_copulation | 2.14392010 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 2.13473859 |
| 26 | MP0005451_abnormal_body_composition | 2.11880221 |
| 27 | MP0003111_abnormal_nucleus_morphology | 2.11844052 |
| 28 | MP0004130_abnormal_muscle_cell | 2.09434058 |
| 29 | MP0000751_myopathy | 2.08672104 |
| 30 | MP0004043_abnormal_pH_regulation | 2.05870880 |
| 31 | MP0003329_amyloid_beta_deposits | 2.03100498 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 2.00272486 |
| 33 | MP0005408_hypopigmentation | 1.98527490 |
| 34 | MP0002735_abnormal_chemical_nociception | 1.94857086 |
| 35 | MP0005360_urolithiasis | 1.92269408 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.89317420 |
| 37 | MP0002734_abnormal_mechanical_nocicepti | 1.87612334 |
| 38 | MP0002572_abnormal_emotion/affect_behav | 1.87544011 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.82512948 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.81570913 |
| 41 | MP0004215_abnormal_myocardial_fiber | 1.79793252 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.79430565 |
| 43 | MP0003195_calcinosis | 1.79088182 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.78455123 |
| 45 | MP0003077_abnormal_cell_cycle | 1.77947167 |
| 46 | MP0003718_maternal_effect | 1.77900300 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.77378325 |
| 48 | MP0008932_abnormal_embryonic_tissue | 1.73178202 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.71313017 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 1.70841177 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.66837423 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.66173223 |
| 53 | MP0006035_abnormal_mitochondrial_morpho | 1.65826747 |
| 54 | MP0004084_abnormal_cardiac_muscle | 1.62177542 |
| 55 | MP0005332_abnormal_amino_acid | 1.61784192 |
| 56 | MP0005535_abnormal_body_temperature | 1.61256148 |
| 57 | MP0001486_abnormal_startle_reflex | 1.59839436 |
| 58 | MP0001727_abnormal_embryo_implantation | 1.58617766 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.57629833 |
| 60 | MP0004924_abnormal_behavior | 1.56075739 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.56075739 |
| 62 | MP0000358_abnormal_cell_content/ | 1.55810355 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.51560607 |
| 64 | MP0004147_increased_porphyrin_level | 1.46229546 |
| 65 | MP0000749_muscle_degeneration | 1.42264774 |
| 66 | MP0001529_abnormal_vocalization | 1.42177599 |
| 67 | MP0004142_abnormal_muscle_tone | 1.41219293 |
| 68 | MP0001970_abnormal_pain_threshold | 1.41078390 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 1.39770483 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.38562797 |
| 71 | MP0008569_lethality_at_weaning | 1.37113607 |
| 72 | MP0010329_abnormal_lipoprotein_level | 1.35770968 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.33210863 |
| 74 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33135431 |
| 75 | MP0008872_abnormal_physiological_respon | 1.32015930 |
| 76 | MP0005365_abnormal_bile_salt | 1.31769987 |
| 77 | MP0005165_increased_susceptibility_to | 1.30204478 |
| 78 | MP0004484_altered_response_of | 1.27905378 |
| 79 | MP0003879_abnormal_hair_cell | 1.27263626 |
| 80 | MP0000604_amyloidosis | 1.27128097 |
| 81 | MP0001730_embryonic_growth_arrest | 1.25378922 |
| 82 | MP0004233_abnormal_muscle_weight | 1.24153704 |
| 83 | MP0005646_abnormal_pituitary_gland | 1.22503003 |
| 84 | MP0001661_extended_life_span | 1.20579564 |
| 85 | MP0002102_abnormal_ear_morphology | 1.18194999 |
| 86 | MP0005620_abnormal_muscle_contractility | 1.18110907 |
| 87 | MP0000747_muscle_weakness | 1.17198328 |
| 88 | MP0005330_cardiomyopathy | 1.16892838 |
| 89 | MP0003633_abnormal_nervous_system | 1.15753736 |
| 90 | MP0001984_abnormal_olfaction | 1.14829708 |
| 91 | MP0002972_abnormal_cardiac_muscle | 1.13816076 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 1.13350255 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 1.11947615 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 1.11338374 |
| 95 | MP0002332_abnormal_exercise_endurance | 1.11262770 |
| 96 | MP0005058_abnormal_lysosome_morphology | 1.07580226 |
| 97 | MP0001905_abnormal_dopamine_level | 1.03354830 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 1.02487505 |
| 99 | MP0003690_abnormal_glial_cell | 1.00714703 |
| 100 | MP0003011_delayed_dark_adaptation | 1.00165891 |
| 101 | MP0003631_nervous_system_phenotype | 0.98837869 |
| 102 | MP0004085_abnormal_heartbeat | 0.98161928 |
| 103 | MP0002269_muscular_atrophy | 0.97971393 |
| 104 | MP0004811_abnormal_neuron_physiology | 0.96319185 |
| 105 | MP0004858_abnormal_nervous_system | 0.95825654 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.95715594 |
| 107 | MP0005501_abnormal_skin_physiology | 0.95249586 |
| 108 | MP0008874_decreased_physiological_sensi | 0.93180695 |
| 109 | MP0002229_neurodegeneration | 0.91430880 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.91322249 |
| 111 | MP0002090_abnormal_vision | 0.91175273 |
| 112 | MP0001853_heart_inflammation | 0.90478224 |
| 113 | MP0001666_abnormal_nutrient_absorption | 0.89928674 |
| 114 | MP0002971_abnormal_brown_adipose | 0.89232259 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.88333936 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.88248952 |
| 117 | MP0004087_abnormal_muscle_fiber | 0.87976023 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.87805266 |
| 119 | MP0000343_altered_response_to | 0.86798949 |
| 120 | MP0008873_increased_physiological_sensi | 0.86679267 |
| 121 | MP0000313_abnormal_cell_death | 0.86527169 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85533309 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.85274078 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.84951850 |
| 125 | MP0001881_abnormal_mammary_gland | 0.84734943 |
| 126 | MP0005670_abnormal_white_adipose | 0.84375255 |
| 127 | MP0002106_abnormal_muscle_physiology | 0.82951365 |
| 128 | MP0008260_abnormal_autophagy | 0.81675722 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.81091633 |
| 130 | MP0003191_abnormal_cellular_cholesterol | 0.80869041 |
| 131 | MP0002184_abnormal_innervation | 0.80217093 |
| 132 | MP0002796_impaired_skin_barrier | 0.79986873 |
| 133 | MP0002557_abnormal_social/conspecific_i | 0.79636029 |
| 134 | MP0002080_prenatal_lethality | 0.78563738 |
| 135 | MP0006138_congestive_heart_failure | 0.78553591 |
| 136 | MP0005266_abnormal_metabolism | 0.77951860 |
| 137 | MP0002069_abnormal_eating/drinking_beha | 0.77390577 |
| 138 | MP0000609_abnormal_liver_physiology | 0.76694842 |
| 139 | MP0000350_abnormal_cell_proliferation | 0.76573760 |
| 140 | MP0005083_abnormal_biliary_tract | 0.76335683 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.74124011 |
| 142 | MP0001764_abnormal_homeostasis | 0.73731708 |
| 143 | MP0001544_abnormal_cardiovascular_syste | 0.73625595 |
| 144 | MP0005385_cardiovascular_system_phenoty | 0.73625595 |
| 145 | MP0009643_abnormal_urine_homeostasis | 0.69503359 |
| 146 | MP0001697_abnormal_embryo_size | 0.66456778 |
| 147 | MP0009333_abnormal_splenocyte_physiolog | 0.66317625 |
| 148 | MP0003941_abnormal_skin_development | 0.60493567 |
| 149 | MP0005376_homeostasis/metabolism_phenot | 0.59597372 |
| 150 | MP0005253_abnormal_eye_physiology | 0.59440818 |
| 151 | MP0005166_decreased_susceptibility_to | 0.58734995 |
| 152 | MP0006072_abnormal_retinal_apoptosis | 0.56839496 |
| 153 | MP0005384_cellular_phenotype | 0.56694264 |
| 154 | MP0003950_abnormal_plasma_membrane | 0.56669564 |
| 155 | MP0002019_abnormal_tumor_incidence | 0.55460093 |
| 156 | MP0001929_abnormal_gametogenesis | 0.55292878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.28913810 |
| 2 | Pheochromocytoma (HP:0002666) | 4.12941465 |
| 3 | Neuroendocrine neoplasm (HP:0100634) | 3.97032094 |
| 4 | Atonic seizures (HP:0010819) | 3.83799973 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.83731707 |
| 6 | Myokymia (HP:0002411) | 3.75817794 |
| 7 | Increased serum pyruvate (HP:0003542) | 3.70059968 |
| 8 | Abnormality of glycolysis (HP:0004366) | 3.70059968 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.59974939 |
| 10 | Acute encephalopathy (HP:0006846) | 3.45255440 |
| 11 | Focal seizures (HP:0007359) | 3.33728961 |
| 12 | Degeneration of anterior horn cells (HP:0002398) | 3.29086348 |
| 13 | Abnormality of the anterior horn cell (HP:0006802) | 3.29086348 |
| 14 | Hepatic necrosis (HP:0002605) | 3.27521768 |
| 15 | Hyperventilation (HP:0002883) | 3.26369478 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.20376782 |
| 17 | Absence seizures (HP:0002121) | 3.19698634 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.16576270 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.13965488 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.13095345 |
| 21 | Abnormality of alanine metabolism (HP:0010916) | 3.10947171 |
| 22 | Hyperalaninemia (HP:0003348) | 3.10947171 |
| 23 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.10947171 |
| 24 | Cerebral edema (HP:0002181) | 3.03377621 |
| 25 | Exercise-induced myalgia (HP:0003738) | 3.02396969 |
| 26 | Myoglobinuria (HP:0002913) | 3.02215844 |
| 27 | Mitochondrial inheritance (HP:0001427) | 2.99468580 |
| 28 | Lipid accumulation in hepatocytes (HP:0006561) | 2.98556993 |
| 29 | Increased CSF lactate (HP:0002490) | 2.93059474 |
| 30 | Generalized tonic-clonic seizures (HP:0002069) | 2.89758402 |
| 31 | Dialeptic seizures (HP:0011146) | 2.89260535 |
| 32 | Visual hallucinations (HP:0002367) | 2.86294741 |
| 33 | Microvesicular hepatic steatosis (HP:0001414) | 2.84207079 |
| 34 | Febrile seizures (HP:0002373) | 2.84071622 |
| 35 | Exercise-induced muscle cramps (HP:0003710) | 2.76737323 |
| 36 | Oligomenorrhea (HP:0000876) | 2.75636495 |
| 37 | Gout (HP:0001997) | 2.73932659 |
| 38 | Lactic acidosis (HP:0003128) | 2.68560091 |
| 39 | Type I transferrin isoform profile (HP:0003642) | 2.66524144 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.66387237 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.63289774 |
| 42 | Ketoacidosis (HP:0001993) | 2.57941303 |
| 43 | Progressive inability to walk (HP:0002505) | 2.57331596 |
| 44 | Increased muscle lipid content (HP:0009058) | 2.55923512 |
| 45 | Hypokinesia (HP:0002375) | 2.53736296 |
| 46 | Resting tremor (HP:0002322) | 2.49092685 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 2.48771178 |
| 48 | Cholecystitis (HP:0001082) | 2.48520305 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.48520305 |
| 50 | Dysmetric saccades (HP:0000641) | 2.47244011 |
| 51 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.45782799 |
| 52 | Cerebral hypomyelination (HP:0006808) | 2.40633817 |
| 53 | Renal Fanconi syndrome (HP:0001994) | 2.40161530 |
| 54 | Ketosis (HP:0001946) | 2.39193863 |
| 55 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.38182403 |
| 56 | Hyperammonemia (HP:0001987) | 2.35956380 |
| 57 | Hyperglycinuria (HP:0003108) | 2.35656011 |
| 58 | Reduced antithrombin III activity (HP:0001976) | 2.35563058 |
| 59 | Increased intramyocellular lipid droplets (HP:0012240) | 2.34833002 |
| 60 | Nemaline bodies (HP:0003798) | 2.34390090 |
| 61 | Anxiety (HP:0000739) | 2.32281580 |
| 62 | Palpitations (HP:0001962) | 2.31606685 |
| 63 | Dysdiadochokinesis (HP:0002075) | 2.30951327 |
| 64 | Impaired social interactions (HP:0000735) | 2.30588064 |
| 65 | Abnormal social behavior (HP:0012433) | 2.30588064 |
| 66 | Cholelithiasis (HP:0001081) | 2.29714872 |
| 67 | Respiratory failure (HP:0002878) | 2.27507909 |
| 68 | Abnormal eating behavior (HP:0100738) | 2.27471979 |
| 69 | Lethargy (HP:0001254) | 2.27199757 |
| 70 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.26407232 |
| 71 | Ragged-red muscle fibers (HP:0003200) | 2.25803728 |
| 72 | Abnormality of glycine metabolism (HP:0010895) | 2.25556488 |
| 73 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.25556488 |
| 74 | Poor eye contact (HP:0000817) | 2.25091513 |
| 75 | Muscle fiber inclusion bodies (HP:0100299) | 2.23564887 |
| 76 | Cerebral hemorrhage (HP:0001342) | 2.22984209 |
| 77 | Nausea (HP:0002018) | 2.22199961 |
| 78 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.20780247 |
| 79 | Aplastic anemia (HP:0001915) | 2.19793115 |
| 80 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.17219602 |
| 81 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.17219602 |
| 82 | Abnormal protein glycosylation (HP:0012346) | 2.17219602 |
| 83 | Abnormal glycosylation (HP:0012345) | 2.17219602 |
| 84 | Status epilepticus (HP:0002133) | 2.16077025 |
| 85 | Rhabdomyolysis (HP:0003201) | 2.16044863 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 2.15974929 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15194351 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.15194351 |
| 89 | 3-Methylglutaconic aciduria (HP:0003535) | 2.15035639 |
| 90 | Muscle stiffness (HP:0003552) | 2.14699813 |
| 91 | Abnormality of serum amino acid levels (HP:0003112) | 2.11799214 |
| 92 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.11180820 |
| 93 | CNS demyelination (HP:0007305) | 2.09868646 |
| 94 | Exercise intolerance (HP:0003546) | 2.09580613 |
| 95 | Hypobetalipoproteinemia (HP:0003563) | 2.09259745 |
| 96 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.08664936 |
| 97 | Sudden death (HP:0001699) | 2.08459491 |
| 98 | Hypoglycemic coma (HP:0001325) | 2.07094155 |
| 99 | Progressive cerebellar ataxia (HP:0002073) | 2.06948870 |
| 100 | Truncal ataxia (HP:0002078) | 2.06006161 |
| 101 | Gaze-evoked nystagmus (HP:0000640) | 2.05815739 |
| 102 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.05661419 |
| 103 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.05661419 |
| 104 | Conjunctival hamartoma (HP:0100780) | 2.03228791 |
| 105 | Increased purine levels (HP:0004368) | 2.03053721 |
| 106 | Hyperuricemia (HP:0002149) | 2.03053721 |
| 107 | Methylmalonic aciduria (HP:0012120) | 2.01889232 |
| 108 | Upper limb muscle weakness (HP:0003484) | 2.01431332 |
| 109 | Myotonia (HP:0002486) | 2.01342441 |
| 110 | Tongue fasciculations (HP:0001308) | 2.01211222 |
| 111 | Action tremor (HP:0002345) | 2.00806268 |
| 112 | Athetosis (HP:0002305) | 1.99344925 |
| 113 | Multiple enchondromatosis (HP:0005701) | 1.99123733 |
| 114 | Leukodystrophy (HP:0002415) | 1.98975120 |
| 115 | Sensorimotor neuropathy (HP:0007141) | 1.98883043 |
| 116 | Hyperglycinemia (HP:0002154) | 1.97923167 |
| 117 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.97250426 |
| 118 | Metabolic acidosis (HP:0001942) | 1.94519378 |
| 119 | Depression (HP:0000716) | 1.93893097 |
| 120 | Increased serum lactate (HP:0002151) | 1.91503902 |
| 121 | Vomiting (HP:0002013) | 1.91387606 |
| 122 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88708721 |
| 123 | Hyperbilirubinemia (HP:0002904) | 1.88015897 |
| 124 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86056268 |
| 125 | Scanning speech (HP:0002168) | 1.86043217 |
| 126 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85625590 |
| 127 | Progressive muscle weakness (HP:0003323) | 1.85432639 |
| 128 | Abnormality of the vocal cords (HP:0008777) | 1.84930012 |
| 129 | Abnormality of the gallbladder (HP:0005264) | 1.84757278 |
| 130 | Urinary urgency (HP:0000012) | 1.83846874 |
| 131 | Neoplasm of the adrenal gland (HP:0100631) | 1.83553093 |
| 132 | Emotional lability (HP:0000712) | 1.83019898 |
| 133 | Esophageal neoplasm (HP:0100751) | 1.81962669 |
| 134 | Dysmetria (HP:0001310) | 1.81764533 |
| 135 | Inability to walk (HP:0002540) | 1.81703779 |
| 136 | Generalized aminoaciduria (HP:0002909) | 1.81560936 |
| 137 | X-linked dominant inheritance (HP:0001423) | 1.80690683 |
| 138 | Methylmalonic acidemia (HP:0002912) | 1.79953321 |
| 139 | Neoplasm of head and neck (HP:0012288) | 1.79357758 |
| 140 | CNS hypomyelination (HP:0003429) | 1.78634778 |
| 141 | Abnormality of placental membranes (HP:0011409) | 1.78583107 |
| 142 | Amniotic constriction ring (HP:0009775) | 1.78583107 |
| 143 | Autoamputation (HP:0001218) | 1.77792259 |
| 144 | Spastic paraparesis (HP:0002313) | 1.77338419 |
| 145 | Posterior subcapsular cataract (HP:0007787) | 1.76918594 |
| 146 | Abnormality of the motor neurons (HP:0002450) | 1.76762005 |
| 147 | Abnormal neuron morphology (HP:0012757) | 1.76762005 |
| 148 | Delusions (HP:0000746) | 1.76084964 |
| 149 | Delayed CNS myelination (HP:0002188) | 1.75387011 |
| 150 | Muscular hypotonia of the trunk (HP:0008936) | 1.75096054 |
| 151 | Tetraparesis (HP:0002273) | 1.74724711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.85108838 |
| 2 | PDK4 | 3.44786359 |
| 3 | PDK3 | 3.44786359 |
| 4 | MAP3K12 | 3.41231693 |
| 5 | EIF2AK3 | 3.34879263 |
| 6 | MST4 | 3.29638868 |
| 7 | PBK | 3.14566791 |
| 8 | NTRK3 | 3.09223577 |
| 9 | SRPK1 | 2.80140422 |
| 10 | MAP3K4 | 2.74021059 |
| 11 | EPHA4 | 2.68104880 |
| 12 | NEK1 | 2.54130152 |
| 13 | MAP3K9 | 2.48992834 |
| 14 | MAP2K7 | 2.47016682 |
| 15 | MAP2K4 | 2.36068907 |
| 16 | TRIM28 | 2.35105023 |
| 17 | MINK1 | 2.33431200 |
| 18 | CASK | 2.31422069 |
| 19 | PDK2 | 2.27327405 |
| 20 | STK16 | 2.25472700 |
| 21 | OXSR1 | 2.18508751 |
| 22 | BCKDK | 2.17656636 |
| 23 | ARAF | 2.15882845 |
| 24 | DAPK2 | 1.92517904 |
| 25 | LMTK2 | 1.91036626 |
| 26 | NME2 | 1.84058638 |
| 27 | TTK | 1.74167587 |
| 28 | PINK1 | 1.66716742 |
| 29 | TESK1 | 1.65332079 |
| 30 | CAMKK2 | 1.65127878 |
| 31 | PLK2 | 1.60020001 |
| 32 | KSR2 | 1.59314462 |
| 33 | ERBB3 | 1.56606039 |
| 34 | CDK19 | 1.55976712 |
| 35 | DAPK1 | 1.54346435 |
| 36 | VRK2 | 1.52922880 |
| 37 | PLK3 | 1.47317251 |
| 38 | NME1 | 1.46753118 |
| 39 | TSSK6 | 1.38767847 |
| 40 | PHKG2 | 1.38669573 |
| 41 | PHKG1 | 1.38669573 |
| 42 | WEE1 | 1.33763773 |
| 43 | TESK2 | 1.33678846 |
| 44 | WNK4 | 1.31572476 |
| 45 | NTRK1 | 1.30977300 |
| 46 | CAMKK1 | 1.30459087 |
| 47 | MAP4K2 | 1.26877313 |
| 48 | PAK6 | 1.24489788 |
| 49 | RIPK4 | 1.23243490 |
| 50 | SGK223 | 1.20618767 |
| 51 | SGK494 | 1.20618767 |
| 52 | PAK4 | 1.20412076 |
| 53 | GRK5 | 1.15706228 |
| 54 | PRKCG | 1.14425271 |
| 55 | MYLK | 1.13989454 |
| 56 | KSR1 | 1.10239028 |
| 57 | AKT3 | 1.08937750 |
| 58 | CDK5 | 1.06455313 |
| 59 | OBSCN | 1.03257759 |
| 60 | SIK3 | 1.02115426 |
| 61 | PRKD3 | 1.01755749 |
| 62 | CCNB1 | 1.01140608 |
| 63 | MST1R | 1.01101655 |
| 64 | BCR | 1.01092235 |
| 65 | CSNK1G3 | 1.00900514 |
| 66 | STK38 | 1.00827358 |
| 67 | STK39 | 0.95736201 |
| 68 | BRSK2 | 0.92627834 |
| 69 | WNK3 | 0.92446175 |
| 70 | CAMK2A | 0.92134784 |
| 71 | CLK1 | 0.90914164 |
| 72 | SGK2 | 0.90380076 |
| 73 | PDPK1 | 0.85954942 |
| 74 | CAMK2G | 0.85468838 |
| 75 | FER | 0.85352480 |
| 76 | MAPKAPK3 | 0.82758454 |
| 77 | MAP2K1 | 0.80131335 |
| 78 | CAMK2B | 0.79992891 |
| 79 | BRAF | 0.79592969 |
| 80 | PLK1 | 0.78575592 |
| 81 | PDK1 | 0.78016574 |
| 82 | MAP3K13 | 0.75543087 |
| 83 | CSNK1G2 | 0.74947791 |
| 84 | PTK2B | 0.73876480 |
| 85 | VRK1 | 0.73440844 |
| 86 | PAK3 | 0.72574500 |
| 87 | PRKCE | 0.72547135 |
| 88 | CAMK2D | 0.72044444 |
| 89 | SGK3 | 0.71617637 |
| 90 | CDK14 | 0.71116120 |
| 91 | PRPF4B | 0.70926423 |
| 92 | MAPKAPK5 | 0.69764039 |
| 93 | EIF2AK2 | 0.68443371 |
| 94 | CDK18 | 0.67904626 |
| 95 | PLK4 | 0.67833689 |
| 96 | SCYL2 | 0.66675853 |
| 97 | LIMK1 | 0.66084937 |
| 98 | CSNK1A1L | 0.66018521 |
| 99 | WNK1 | 0.65848127 |
| 100 | EIF2AK1 | 0.65813240 |
| 101 | ERBB4 | 0.63518208 |
| 102 | MAP2K6 | 0.63383060 |
| 103 | PRKCH | 0.63340894 |
| 104 | CDC7 | 0.62226447 |
| 105 | ALK | 0.61913520 |
| 106 | EPHA2 | 0.61701745 |
| 107 | DAPK3 | 0.61518228 |
| 108 | CSNK1G1 | 0.59486219 |
| 109 | PNCK | 0.59222960 |
| 110 | MAP3K2 | 0.59061972 |
| 111 | CDK15 | 0.58955265 |
| 112 | KDR | 0.58322446 |
| 113 | RET | 0.57060000 |
| 114 | RPS6KA4 | 0.56525939 |
| 115 | TRIB3 | 0.55264677 |
| 116 | LATS2 | 0.54886099 |
| 117 | BMPR2 | 0.54366260 |
| 118 | NTRK2 | 0.54295955 |
| 119 | BRSK1 | 0.52267180 |
| 120 | ZAK | 0.51059482 |
| 121 | AURKB | 0.50612552 |
| 122 | IRAK3 | 0.50001529 |
| 123 | PIM2 | 0.48478466 |
| 124 | ILK | 0.47781400 |
| 125 | AKT2 | 0.45321184 |
| 126 | ATR | 0.45320862 |
| 127 | SGK1 | 0.45233918 |
| 128 | FES | 0.45112397 |
| 129 | MAP3K1 | 0.44196833 |
| 130 | MARK1 | 0.44164957 |
| 131 | MAPK12 | 0.43989069 |
| 132 | CSNK2A2 | 0.43451831 |
| 133 | CDK11A | 0.43076740 |
| 134 | CSNK2A1 | 0.42689310 |
| 135 | RAF1 | 0.41872303 |
| 136 | PRKACA | 0.41238125 |
| 137 | MAP3K5 | 0.41050197 |
| 138 | PRKACG | 0.40333632 |
| 139 | ACVR1B | 0.39021580 |
| 140 | ROCK2 | 0.38845744 |
| 141 | ABL2 | 0.38251537 |
| 142 | PAK1 | 0.37886795 |
| 143 | CAMK1 | 0.36676623 |
| 144 | NUAK1 | 0.36187374 |
| 145 | TTN | 0.36001002 |
| 146 | NEK9 | 0.35569535 |
| 147 | NEK6 | 0.34528823 |
| 148 | STK10 | 0.33445579 |
| 149 | STK11 | 0.33304897 |
| 150 | STK4 | 0.32666719 |
| 151 | MAP3K8 | 0.32465805 |
| 152 | GRK7 | 0.32086722 |
| 153 | RPS6KA3 | 0.31283013 |
| 154 | PRKCA | 0.31096214 |
| 155 | TXK | 0.30324159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.57579346 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40069155 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.32188069 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.79402103 |
| 5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.57608144 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.53025219 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.51004612 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.39178244 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.34658949 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.33168513 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.23681202 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.15676374 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.03629243 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.01140999 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95849036 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.92984963 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.92165833 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90019459 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.76827272 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.74593737 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.69870266 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68647147 |
| 23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.68271067 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66949380 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60292660 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.54012146 |
| 27 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.52399204 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47286488 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44813272 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.43709784 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40769705 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39364634 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38953753 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.38279885 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.36105700 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34836720 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 1.31810074 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31617559 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29920444 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28783269 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28131911 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.26704886 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.26651025 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25516586 |
| 45 | Circadian entrainment_Homo sapiens_hsa04713 | 1.24506281 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.24185624 |
| 47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21579121 |
| 48 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.21472725 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20033761 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.16573500 |
| 51 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.09104359 |
| 52 | RNA transport_Homo sapiens_hsa03013 | 1.08699535 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.07467213 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 1.05745645 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 1.04300687 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 1.04075709 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.03430968 |
| 58 | Base excision repair_Homo sapiens_hsa03410 | 1.02323498 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01913565 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99978792 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 0.99665404 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99298092 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98749529 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95964257 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.95820303 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95666207 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.91604422 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.91128966 |
| 69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.87995315 |
| 70 | Ribosome_Homo sapiens_hsa03010 | 0.86376785 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.85765783 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85032859 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84542653 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84021736 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83054307 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80843566 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80275885 |
| 78 | Taste transduction_Homo sapiens_hsa04742 | 0.80116461 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79500464 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79472288 |
| 81 | RNA degradation_Homo sapiens_hsa03018 | 0.79381439 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.79129025 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78695828 |
| 84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77221407 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.77104772 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.74982240 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69834389 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69073238 |
| 89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67979533 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67750903 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67616224 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65594813 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64672212 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64250931 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62595043 |
| 96 | Long-term depression_Homo sapiens_hsa04730 | 0.60937706 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60138181 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58610299 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58275478 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56335234 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56128192 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55394228 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54309538 |
| 104 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53866263 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.53691610 |
| 106 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53060558 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52674758 |
| 108 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52214431 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52189421 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50958725 |
| 111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50897229 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49789669 |
| 113 | Cell cycle_Homo sapiens_hsa04110 | 0.49331306 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45899684 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43334801 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43323281 |
| 117 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43285576 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43056072 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42211330 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41922496 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41346469 |
| 122 | Proteasome_Homo sapiens_hsa03050 | 0.40592093 |
| 123 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39945849 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.39704312 |
| 125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39692256 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.38708363 |
| 127 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37464004 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36846003 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36156848 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35875803 |
| 131 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35820350 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34238954 |
| 133 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33898543 |
| 134 | Legionellosis_Homo sapiens_hsa05134 | 0.32294203 |
| 135 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31110464 |
| 136 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30461579 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30365988 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29906878 |
| 139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29454841 |
| 140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29209196 |
| 141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.28458577 |
| 142 | Phagosome_Homo sapiens_hsa04145 | 0.28361406 |
| 143 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28073296 |
| 144 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27666040 |
| 145 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.27527136 |
| 146 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27288872 |
| 147 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25237260 |
| 148 | Retinol metabolism_Homo sapiens_hsa00830 | 0.22698037 |
| 149 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.18505752 |
| 150 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.16825614 |
| 151 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.16098190 |

